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Abstract Because uranium is a natural element present
in the earth’s crust, the population may be chronically
exposed to low doses of it through drinking water.
Additionally, the military and civil uses of uranium can
also lead to environmental dispersion that can result in
high or low doses of acute or chronic exposure. Recent
experimental data suggest this might lead to relatively
innocuous biological reactions. The aim of this study was
to assess the biological changes in rats caused by inges-
tion of natural uranium in drinking water with a mean
daily intake of 2.7 mg/kg for 9 months and to identify
potential biomarkers related to such a contamination.
Subsequently, we observed no pathology and standard
clinical tests were unable to distinguish between treated
and untreated animals. Conversely, LC–MS metabolomics
identified urine as an appropriate biofluid for discrimi-
nating the experimental groups. Of the 1,376 features
detected in urine, the most discriminant were metabolites
involved in tryptophan, nicotinate, and nicotinamide
metabolic pathways. In particular, N-methylnicotinamide,
which was found at a level seven times higher in
untreated than in contaminated rats, had the greatest dis-
criminating power. These novel results establish a proof
of principle for using metabolomics to address chronic
low-dose uranium contamination. They open interesting
perspectives for understanding the underlying biological
mechanisms and designing a diagnostic test of exposure.
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1 Introduction
Above and beyond acute accidental pollution by various
substances, the chronic low-rate dispersion of pollutants to
the environment is a serious health issue that raises ques-
tions about the effects on humans of such continuous low-
grade exposure. The potential health repercussions are not
always satisfactorily addressed. Thus both the public and
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more directly involved stakeholders request studies to
evaluate the environmental risks related to exposure to
these various low-grade pollutants (European-Commission
2011). Radionuclides are among the most interesting of
the environmental chemical compounds for experimental
studies because of the societal concerns they raise. They
can be dispersed after major nuclear power plant accidents
(for example, cesium 137) (Gagnaire et al. 2010) or by
military activity with depleted uranium (Handley-Sidhu
et al. 2010). Other radionuclides are naturally occurring
elements present in rocks, water, and the food chain, such
as uranium (Bleise et al. 2003; Craft et al. 2004), which
can also be dispersed in higher quantities by pit mining
(Arogunjo et al. 2009). The consequences of acute high
doses of uranium on health are relatively well known
(Kathren and Burklin 2008) and have been described in
particular in kidneys. However, the long-term effects of
low-dose uranium contamination remain unknown and
require more investigation. Several in vivo studies have
shown that uranium can affect various physiological sys-
tems, including intestinal inflammatory pathways, the
reproductive system, brain pro- and anti-oxidant activity,
and xenobiotic metabolisms (Briner 2010; Dublineau et al.
2006, 2007; Feugier et al. 2008; Lestaevel et al. 2009;
Paquet et al. 2006; Souidi et al. 2009; Wade-Gueye et al.
2012). Nonetheless, a still more sensitive approach is
necessary to overcome the specific limitations due to low
doses. Metabolomics, a noninvasive technology suitable
for clinical studies (Zhang et al. 2012; Corona et al. 2012;
Senn et al. 2012), has recently been proven quite powerful
for identifying a discriminant metabolic signature of
chronic low-dose cesium 137 contamination in rats (Gri-
son et al. 2012). The aim of this study was thus to use a
metabolomic approach, combined with conventional tox-
icology, to characterize the biological impact of chronic
low-dose exposure to natural uranium (nat.U) in rats by an
exhaustive metabolite analysis and to attempt to decipher
potential underlying molecular mechanisms. To mimic
environmental contamination of drinking water, especially
among children, who are known to be a sensitive sub-
group in toxicology (Schwenk et al. 2003; Wang and
Pinkerton 2007) and radiobiology (De Santis et al. 2007;
Magdo et al. 2007), rats were exposed from birth to
adulthood through drinking water containing a concen-
tration of nat.U known not to be toxic to the kidneys.
Standard clinical and biological characteristics, including
body and organ weight, food and water consumption,
blood cell counts, and plasma and urine biochemistry
were assessed to verify the absence of toxicity. At the
same time, we used liquid chromatography–mass spec-
trometry (LC–MS) to acquire exhaustive urine metabolite
profiles, which we analyzed by multivariate statistical
methods.
2 Materials and methods
2.1 Animals and contamination procedure
2.1.1 Animals
Sprague–Dawley rats, 12 weeks old and 16 days pregnant,
were obtained from Charles River Laboratories (L’Arbre-
sle, France). They were housed individually and main-
tained in a 12-h light/12-h dark cycle (regular cycle) at
21 C and 50 % humidity, with access to a standard rodent
pellet diet and water ad libitum. After weaning, male off-
spring were housed, each paired with a rat from a different
mother (assigned by randomization). Female offspring and
mothers were euthanized. All experimental procedures
were approved by the Animal Care Committee of the
Institute of Radioprotection and Nuclear Safety (IRSN) and
complied with French regulations for animal experimen-
tation (Ministry of Agriculture Act No. 87-848, October
19, 1987, modified May 20, 2001).
2.1.2 Contamination procedure
Rats were contaminated through their drinking water: nat.U
in a solution of uranyl nitrate hexahydrate (UO2(NO3)2
6H2O) was prepared to a final uranium concentration of
40 mg L-1 (daily uranium intake: 1 mg/rat/day) and dis-
solved in mineral water. This dose corresponds to three
time as much as the highest uranium concentration found
naturally in well waters in Finland (Salonen 1994). nat.U
(Olympic) was obtained from CERCA (Pierrelatte,
France). Control animals drank uncontaminated mineral
water. The specific activity of the nat.U was 2.42 9 10
?4
Bq/g and its isotopic composition was 238U = 99.307,
235U = 0.688, and 234U = 0.005 %. Mothers of the off-
spring in the treated group were also exposed to nat.U
through drinking water from birth to euthanasia (mothers
of the control rats received uncontaminated mineral water).
Until weaning, offspring were theoretically contaminated
by mother’s milk [human offspring receive *5 % of the
mother’s daily dose (Wappelhorst et al. 2002)]. The food
and water intake of both groups were monitored weekly
throughout the contamination period.
2.2 Collection of organs and biofluids
One morning when the rats were 9 months old, they were
placed in metabolic cages (one per cage), with access to a
rodent ground pellet diet and water (contaminated or not)
ad libitum. Urine was collected twice a day for 48 h, with
sodium azide (0.01 %) added to prevent bacterial growth
(Griffin et al. 2001), and refrigerated at ?4 C. Each rat’s
fractions were pooled, mixed, and centrifuged; supernatants
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were frozen at -80 C. The rats were then moved to con-
ventional cages (one per cage) with food and drink ad libi-
tum until the evening to reduce stress. To control the diet
cycle, food was removed in the evening until the next
morning. Five hours before euthanasia, around 12 g of
standard rodent pellet food was added directly to each cage
to stimulate the desire to eat before sleep. Rats were anes-
thetized by inhalation of 5 % isoflurane (Abbot France,
Rungis, France) and euthanized by intracardiac puncture,
with blood collected in heparinized tubes. Whole blood was
centrifuged (5,000 rpm) and plasma supernatants were
immediately frozen at -80 C. Organs were dissected
on ice, weighed, deep-frozen in liquid nitrogen, and stored at
-80 C.
2.3 Biological and uranium analyses
2.3.1 Measurement of biological characteristics
2.3.1.1 Blood cell counts Complete blood counts (CBC)
were performed with an MS-9 vet automatic counter
(Melet-Schlossing, Osny, France). Remaining blood was
centrifuged at 400 g for 10 min, and plasma was frozen
(-80 C) for later use.
2.3.1.2 Biochemical panel Biochemical measurements
were made from thawed plasma samples by an automated
spectrometric system (Konelab 20 from Thermo Electron
Corporation, Cergy-Pontoise, France), with the manufac-
turer’s biological chemistry reagents and protocols. The
markers measured in plasma included glucose, albumin,
total protein, lactate dehydrogenase (LDH), alkaline
phosphatase (ALP), cholesterol, high-density lipoprotein
(HDL), low-density lipoprotein (LDL), phospholipids, tri-
glycerides, alanine aminotransferase (ALT), aspartate
aminotransferase (AST), total and direct bilirubin, trans-
ferrin, ferritin, ceruloplasmin iron, phosphorus, calcium,
chlorine, potassium, magnesium, sodium, urea, creatinine,
and creatine kinase.
2.3.2 Measurement of uranium accumulation and dose
calculation
2.3.2.1 Measurement of natural uranium organ contami-
nation Samples were mineralized (Ejnik et al. 2000) and
then analyzed for their uranium content by ICP-MS
(XSERIE 2, Thermoelectron, France). A multielement
standard solution (Analab, France) was used to optimize
experimental conditions and apparatus parameters to obtain
the best signal/noise ratio for 238U. In all solutions likely to
be analyzed (biological samples or calibration solutions),
bismuth 209 was added as an internal standard at 1 lg L-1.
Six standard solutions for the calibration curve (0, 0.005,
0.01, 0.1, 0.5, and 1 lg L-1) were freshly prepared by
dilution of a standard solution at 10 mg L-1 in 2 % nitric
acid (NORMATOM for trace metal analysis, VWR Pro-
labo). A linear relation—count number (iU) = f([iU])—can
thus be set up for each isotope, i = [235; 238] with [iU]
equal to the isotope concentration in lg L-1. Isotopy and
dosage reliability were regularly verified with standard
solutions (six quality controls of different concentrations
and isotopy distributed throughout the analysis). Blank
samples were run every five samples to check the stability
of the background and prevent potential contamination. For
238U, the detection and quantification limits were respec-
tively 0.5 and 1.5 ng/L, and for 235U, 0.01 and 0.03 ng/L.
The limits for 238U were applied to total uranium.
2.3.2.2 Renal dose estimation (9 months post-natal) The
radiation yields and energies of radiation emitted in nuclear
transformation of the isotopes forming nat.U were taken
from ICRP (1983). Alpha particles and Auger and internal
conversion electrons were assumed to be locally absorbed
in the source organ. Photons were transported with the code
MCNPX in a voxel phantom of an adult male rat from the
same strain. In view of the preponderant concentration of
nat.U in kidneys (Table 1) and the small fraction of energy
emitted as penetrating radiation, kidney irradiation by nat.U
from the rest of the body was ignored because negligible.
The absorbed dose rate to the kidney was thus determined
at 9 months of age based on the kidney concentration of
nat.U and kidney mass indicated in Table 1 and assuming a
homogeneous concentration of nat.U throughout the entire
9 months.
2.3.3 Statistical analysis
This animal protocol of nat.U contamination used two groups
each of 10 rats. Health diagnostic values were reported as
means ± standard errors of the means (SEM). The control
and contaminated groups were compared with student’s
t test in normal populations or the rank sum test in non-
normal populations. Statistical significance was defined by a
P value \ 0.05. Statistical analyses were performed with
Sigmastat statistical software (SPSS, Paris, France).
2.4 Metabolomic analysis
2.4.1 Sample preparation
Urine samples were diluted immediately before analysis.
After centrifugation for 15 min at 11,000 rpm and 4 C,
100 lL of thawed urine was mixed and shaken for 1 min
with 400 lL of deionized water. After a second centrifu-
gation for 5 min at 3,000 rpm, 50 lL of supernatant was
transferred into HPLC vials for analysis.
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To check for data quality, a blank sample (deionized
water) and a pool sample (a mixture of all samples) were
extracted/diluted and analyzed repeatedly along with the
sample series.
2.4.2 LC–MS analyses
The samples were analyzed on an Agilent 1200 RRLC
coupled to a Bruker microTOF ESI-hybrid quadrupole-
time of flight mass spectrometer (Wissembourg, France).
For polar compounds from plasma, the LC conditions
were: autosampler temperature, 4 C; column type, EC
100/2 Nucleodur C18 pyramid; particle size, 1.8 lm
(Macherey–Nagel, Les Ulis, France); column temperature,
40 C; solvent flow, 0.4 mL/min (solvent A: 95 % water,
5 % acetonitrile, 0.1 % formic acid, and solvent B: 95 %
acetonitrile, 5 % water, 0.1 % formic acid); gradient, 3 %
B for 1 min, 3–50 % B for 2 min, 50–100 % B for 6 min,
100 % B for 2 min, 100–3 % B for 1 min, and 3 % B for
4 min (running time, 16 min).
The MS conditions were as follows: acquisition mode,
positive electrospray ionization (ESI?) and full scan
50–1,500 m/z; capillary voltage, 4.5 kV; capillary temper-
ature, 200 C; cone voltage, 40 V; drying gas flow,
9.5 L min-1; nebulizing gas pressure (nitrogen), 2.9 bar.
For metabolite identification purpose, MS/MS analyses
were performed on selected urine samples and standard
molecules. LC and MS methods were used for the MS anal-
yses, and MRM parameters were set at 8.0 for isolation width,
2.0 for acquisition factor, and 10.0, 20.0 and 30.0 eV for
collision energies. Creatine (MET250A), 4,6-dihydroxy-
quinoline (424048—250MG), and 5-hydroxyindoleacetate
Table 1 Mean ± SEM of (i) uranium concentration in plasma, urine
and kidneys, (ii) dietary consumption measured over the 4 months
before euthanasia, (iii) whole-body weight, kidney weight and mean
ratio of kidney to whole-body weight in each group, (iv) 48-h urine
collection, (v) plasma enzymes, proteins, carbohydrates, lipids, ions
and other metabolites, (vi) urine proteins, carbohydrates, ions, other
metabolites and creatinine clearance evaluation in control and
contaminated (nat.U) groups after 9 months of chronic radionuclide
ingestion through drinking water (40 mg/L)
Uranium concentrations Control (10) nat.U (10) Plasma analysis Control (9) nat.U (10)
Plasma (ng U/g) 0.86 ± 0.05 0.92 ± 0.06 ALAT/GPT (U/L) 37.2 ± 4.5 36.5 ± 2.6
Kidney (ng U/g) 5.45 ± 0.64 358.94 ± 84.02*** ASAT/GOT (U/L) 69.8 ± 4.6 89.5 ± 5.0**
Urine (ng U/g) 2.00 ± 0.24 14.99 ± 1.08*** CK (U/L) 184.0 ± 19.9 259.9 ± 36.2
Dietary consumption CK-MB (U/L) 335.2 ± 44.9 386.2 ± 42.5
Drinking (mL/day/rat) 27.1 ± 0.3 28.8 ± 0.2 LDH (U/L) 512.2 ± 87.1 532.5 ± 56.2
Food consumption (g/day/rat) 28.0 ± 0.3 26.0 ± 0.3 ALP (U/L) 76.7 ± 4.7 66.4 ± 5.4
Weight measured at sacrifice CERU (mg/L) 98.3 ± 7.7 91.6 ± 10.0
Total body (g) 615 ± 26 563 ± 18* CHE (U/L) 154.6 ± 43.1 98.2 ± 6.9
Kidney (g) 1.72 ± 0.04 1.77 ± 0.05 Albumin (g/L) 30.4 ± 0.4 30.7 ± 0.6
Ratio kidney/total body (%) 0.28 0.32* Total proteins (g/L) 61.4 ± 1.0 54.7 ± 5.9
48-h urine collection Transferrin (g/L) 1.5 ± 0.1 1.5 ± 0.0
Urine volume (g) 28 ± 2 32 ± 1 Glucose (g/L) 11.7 ± 0.6 11.8 ± 0.4
Triglycerides (mM) 1.0 ± 0.2 0.9 ± 0.1
Urine analysis Control (10) nat.U (10) Cholesterol (mM) 2.5 ± 0.2 2.4 ± 0.2
Amylase (U) 335.90 ± 24.60 342.47 ± 21.12 HDL-cholesterol (mM) 1.1 ± 0.1 1.2 ± 0.1
Glucose (mmol) 0.06 ± 0.01 0.06 ± 0.00 LDL-cholesterol (mM) 0.4 ± 0.0 0.3 ± 0.0
Calcium (mmol) 0.06 ± 0.00 0.08 ± 0.01 Phospholipids B (g/L) 1.5 ± 0.1 1.4 ± 0.1
Potassium (mmol) 0.55 ± 0.28 1.56 ± 0.35** Calcium (mM) 2.6 ± 0.1 2.6 ± 0.0
Sodium (mmol) 0.63 ± 0.33 1.71 ± 0.39** Iron (lM) 21.8 ± 1.3 23.4 ± 1.4
Phosphorus (mmol) 0.81 ± 0.10 0.55 ± 0.07 Chlorine (mM) 93.0 ± 1.9 93.8 ± 1.0
Total proteins (g) 0.11 ± 0.03 0.08 ± 0.02 Potassium (mM 4.2 ± 0.1 4.5 ± 0.2
Urea (mmol) 26.56 ± 2.08 26.23 ± 1.11 Magnesium (mM) 0.7 ± 0.0 0.6 ± 0.1
Uric acid (lmol) 45.97 ± 2.22 47.51 ± 2.80 Phosphorus (mM) 1.3 ± 0.1 1.4 ± 0.1
Creatinine (lmol) 333.17 ± 19.83 328.79 ± 20.41 Creatinine (lM) 43.7 ± 1.0 47.6 ± 1.5*
Creatinine clearance (ml/min/kg) 4.4 ± 0.2 4.3 ± 0.2 Direct bilirubin (lM) 3.0 ± 0.3 3.0 ± 0.2
Total bilirubin (lM) 2.1 ± 0.3 2.3 ± 0.2
Urea (mM) 5.7 ± 0.2 5.7 ± 0.2
The number of rats for each measurement is indicated in parentheses
Results are significantly different for: * P \ 0.05; ** P \ 0.01; *** P \ 0.001
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(H8876—100MG) were purchased from Sigma (St. Quentin
Fallavier, France) and N1-methylnicotinamide (M0375—
10 g) from TCI Europe (Zwijndrecht, Belgium). Solutions of
1 mg/mL were prepared in different solvent mixtures
according to each molecule’s Log P value (water with 0.1 %
formic acid for creatine, with 2 % acetonitrile for N1-meth-
ylnicotinamide, and with 10 % acetonitrile for the others) and
injected at a 10 lg/mL concentration.
2.4.3 Data preprocessing and filtering
LC–MS raw data were exported to ‘‘.cdf’’ file format with
the manufacturer’s software DataAnalysis (Bruker, Wiss-
embourg, France) and preprocessed with the freely avail-
able XCMS software including the CAMERA script (Smith
et al. 2006). Peak picking was performed with the ‘cent-
Wave’ method (‘peakwidth’ parameter reduced to 3–15 s
to fit to UPLC performance, and ‘snthresh’ to 5 to detect
more peaks), retention time correction with the obiwarp
method (‘profStep’ reduced to 0.1 m/z as recommended for
QTOF mass spectrometers), peak grouping with ‘bw’ and
‘mzwidth’ parameters reduced to 5 and 0.025, respectively,
and gap filling with the default parameters.
To check for and ensure data quality, three successive
filtering steps were applied to the pre-processed data using
an in-house script ran on R, based on the signal/noise ratio
of each MS feature in the pool samples (cutoff set at 5
between features matching both in biological and blank
samples), the coefficient of variation of the intensity of the
variables in the pool samples (cutoff set at 20 %) and the
coefficient of the autocorrelation of the variables in a given
‘pcgroup’ (cutoff set at 0.8). Preprocessing and filtering of
the raw LC–MS data reduced the number of variables from
3,446 to 1,376 (40 %) in urine.
2.4.4 Statistical analyses
The most discriminatory metabolites were sought in the
dataset based on partial least-square discriminant analysis
(PLS-DA) using the variable importance in projection (VIP)
procedure. All multivariate statistical analyses were performed
with SIMCA-P? 12.0 software (Umetrics, Umea˚, Sweden).
For each discriminatory compound, a receiver operating
characteristic (ROC) curve as well as the area under this
ROC curve (AUC) were computed with the R package
pROC. A 95 % confidence interval was assessed for sen-
sitivity with 2000 bootstrap replicates. A boxplot by group
was calculated for each compound selected.
2.4.5 Metabolite identification
The 40 most discriminatory metabolites were searched in
the MZedDB, a web browser screening several databases
simultaneously, for tentative annotation using the accurate
measured mass (accuracy \15 ppm) (http://maltese.dbs.
aber.ac.uk:8888/hrmet/index.html) (Draper et al. 2009) and
the Bru¨ker Data Analysis molecular formula engine, using
isotopic patterns. The KEGG compound ID of any hits was
recorded, and all recorded IDs were inserted into the
KEGG Mapper (http://www.genome.jp/kegg/tool/map_
pathway2.html) for tentative pathway identification. For
the compounds involved in the first four proposed path-
ways, a standard molecule was purchased, when available,
and subjected to MS/MS analysis. We compared spectral
data obtained with standard molecules and experimental
samples to one another and searched for matches in the
Metlin (http://metlin.scripps.edu/spec_search.php), Mass-
Bank databases (http://www.massbank.eu/MassBank/), or
HMDB (http://www.hmdb.ca/spectra/ms/search).
3 Results
3.1 Uranium intake and dose calculations
Results confirmed that the kidney is a preferential target
organ for uranium accumulation (Table 1); uranium con-
centration was very low in plasma (close to the natural
background) and significantly higher in urine.
At 9 months of age, the absorbed dose rate in the kid-
neys of the contaminated rats was estimated at
5.4 9 10-7 Gy d-1. Under the maximizing assumption of
a constant dose rate over 9 months, the maximum dose
absorbed by the kidneys at sacrifice should still be as low
as 0.15 mGy (considering a homogeneous concentration of
nat.U throughout the entire 9-month period).
3.2 Effect of uranium contamination on biological
characteristics
We monitored drinking water and food consumption during
the 4 months preceding the end of the contamination (once
a week). Control and contaminated rats did not differ in
their food consumption or water intake (Table 1).
To identify any toxic morphological changes, we
weighed the whole body and one kidney (on the same side
for each) for all rats and compared the groups. Calculation of
relative organ weights showed a slight statistical difference
but excluded any appreciable physiological effect (Table 1).
No difference between the groups was observed for the
urine volume collected during the 48-h period shortly
before sacrifice (Table 1).
Blood counts did not differ between the groups after
contamination (supplemental Table 1).
Several biochemical markers in plasma were also assessed,
including proteins, ions, and liver, cardiovascular, and kidney
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markers (Table 1). Except for slightly elevated AST-GOT
(P B 0.01) and creatinine (P B 0.05) levels in the contami-
nated rats (nonetheless within the physiological range), no
differences were observed between the groups.
Similarly, urine sodium and potassium levels were sta-
tistically higher in contaminated than in control rats, but
remained in the normal range as did the measurement of
creatinine clearance, which showed no significant differ-
ence between the groups (Table 1).
3.3 Effect of uranium contamination on urinary
metabolites
3.3.1 Discrimination between control and contaminated
rats by urine samples
The PLS-DA performed on the 1,376 features detected in
urine samples resulted in robust, validated discrimination
between the control rats and those contaminated with the
nat.U (R2 = 92 %, Q2 = 55 %, CV-ANOVA = 0.009).
The 95 most discriminating variables, selected according to
their VIP score (above 1.8), were used for another PCA.
The first principal component described 40 % of total
variance and could be interpreted as the inter-group vari-
ation, while the second principal component described
14 % of total variance and showed the interindividual
variability (Fig. 1a). Of the discriminant features, 60 %
were characteristic of the contaminated group (Fig. 1b).
Using the same 95 features, a new PLS-DA model was
fitted to identify the top 40 discriminating features
(Table 2). According to the PCA results, only one PLS-DA
component was necessary for significant discrimination
between control and contaminated rats (R2 = 89 %,
Q2 = 74 %, CV-ANOVA\0.0005) (plot not shown). The
discriminatory power of the top 40 features is quite satis-
factory as their AUC under the ROC curve was above
71 % (above 80 % for the top 27). The AUC of the first
discriminatory metabolite was even 100 % (Fig. 2).
3.3.2 Urinary metabolites responsible for discriminating
between control and contaminated rats
Of the top 40 discriminatory metabolites in urine samples
(Table 2), 36 were tentatively annotated with the MZedDB
database browser, and 28 had a corresponding KEGG ID.
Fourteen of these 28 were mapped in pathways according
to the KEGG Mapper search: 8 in the tryptophan metab-
olism pathway, 7 in global metabolic pathways, and 2 in
the nicotinate and nicotinamide metabolism pathway. Eight
of these 14 molecules were available from suppliers and
purchased for further analytical confirmation.
N1-methylnicotinamide (also called trigonellinamide),
creatine and 4,6-dihydroxyquinoline were proposed to be
[M?H]1? forms of the molecules, so the target masses for
MS/MS analyses were the same for the standards and the
U50 urine sample, which had the highest intensities for
these metabolites.
The Metlin spectrum search result for N-methylnicoti-
namide was a match for both the standard and U50 sample
(supplemental Fig. 1) samples. In U50, the main fragments
obtained at 20 eV collision energy were the precursor
(m/z 137.073) and m/z 94 (loss of the carbamaldehyde
group). Such a spectrum was also found in MassBank and
HMDB. Matched retention time at 30 s between the
authentic standard and the m/z 137.07 ion trace in the urine
samples was additionally confirmatory.
The Metlin spectrum search result for creatine was also
a match for both the standard and U50 (supplemental
Fig. 2) samples. The main fragments obtained at 20 eV
collision energy were the precursor (m/z 132.07) and
m/z 90.053 (loss of the methanimidamide group). Such a
Fig. 1 Principal component analysis (PCA) performed on the 95
most discriminatory urine metabolites (VIP score C 1.8 in the PLS-
DA model built with the 1,376 urine metabolites). a Score scatter
plot; PC1 and PC2 describe 40 and 13 % of the total variance,
respectively. b Loading scatter plot; 60 % of the discriminant features
characterize the contaminated rats (left-hand side on the plot)
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spectrum was also found in MassBank and HMDB.
Another fragment, m/z 111.057, is present in U50 at a high
intensity (and also in MassBank database at a much lower
intensity). The commensurate increase of creatine peak
height at 31 s by spiking the urine sample with various
amount of an authentic standard also brought a supple-
mentary chromatographic confirmation.
There was no spectrum match for 4,6-dihydroxyquino-
line in either Metlin, MassBank or HMDB, due to the lack
of MS/MS data in these databases for this particular
compound. Nevertheless two quite superimposable frag-
ment spectra were obtained for the standard and U50
samples at 138.6 s retention time (supplemental Fig. 3).
The main fragments obtained at 20 eV collision energy
were the precursor ion (m/z 162.05) and a fragment at
m/z 144.05 (loss of a water molecule). Spiking the urine
sample with the authentic standard also brought a chro-
matographic confirmation.
MZedDB proposed adduct/fragment ions for 5-hydrox-
yindoleacetic acid, the other tentatively annotated
molecules. The Metlin spectrum search result was a match
for both the standard and (supplemental Fig. 4) samples:
both fragment and precursor were clearly co-detected in the
urine sample, at the same retention time. The main frag-
ments obtained at 10 eV collision energy were the pre-
cursor (m/z 192.07) and an ion at m/z 146.06 (loss of a
formic acid molecule). Such a spectrum was also found in
HMDB, but there was no QTOF spectrum in MassBank for
this metabolite. At 30 eV, 2 other fragments appeared in
the standard: m/z 128.05 (loss of a carbonic acid) and
118.07 (loss of a formaldehyde group from the 146.06 ion).
Again spiking the urine sample with increasing amount of
an authentic standard additionally argued for identification
(supplemental Fig. 4).
According to the minimum metadata relative to metab-
olite identification of non-novel compounds proposed by
the metabolomics standard initiative (Sumner et al. 2007),
we have thus far identified 4 metabolites, the concentra-
tions of which were modified after chronic low-dose
uranium contamination: 1-methylnicotinamide, creatine,
Fig. 2 Receiver operating
characteristic (ROC) curve and
area under the curve (AUC) of
the 4 metabolites identified
among the top 40 for
discriminating the control from
the contaminated rats.
According to their VIP score,
these metabolites were ranked
1st (M137T30), 6th (M132T32),
11th (M162T107) and 32th
(M146T272)
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4,6-dihydroxyquinoline (reduced concentration in the urine
of contaminated rats) and 5-hydroxyindoleacetic acid
(increased concentration in the urine of the contaminated
rats).
4 Discussion
Thus far, experimental studies of rat models exposed to
chronic low-dose uranium contamination have shown
metabolic changes without the onset of any morbidity. For
example, targeted analysis of biochemical systems has
revealed deregulation of the xenobiotic, cytochrome P450,
Vitamin D, cholesterol, iron, and acetyl choline metabo-
lisms (Berradi et al. 2008; Bussy et al. 2006; Gueguen et al.
2007; Racine et al. 2010; Souidi et al. 2005; Tissandie et al.
2007). Nevertheless, documentation of the effects of low-
dose nat.U contamination remains poor, likely due to the
difficulty in demonstrating any health impact of a com-
pound absorbed at a very low dose, possibly over a long
period. A very sensitive method is required to investigate
such potentially low-grade effects. We previously applied
untargeted metabolomics in similar conditions to examine
chronic low-dose 137Cs contamination and found that this
approach showed promise for revealing metabolic disrup-
tion where other conventional methods failed to discrimi-
nate between exposed and unexposed rats (Grison et al.
2012).
Here, we sought to evaluate the effects of chronic low-
dose exposure to nat.U on rat health, both with conventional
toxicological tests, such as organ weighing and urine/
plasma biochemical assays, and with a metabolomic
approach based on analysis of urinary LC–MS profiles. To
mimic the potential natural exposure of human populations,
rats were chronically contaminated through drinking water
at a daily intake of about 1 mg per animal. This dose
corresponds to three times as much as the maximum nat-
ural concentration measured in Finnish wells and can be
considered a realistic level of natural contamination
(Salonen 1994). Moreover, no renal toxicity has been
demonstrated at this dose in rats.
As previously described after 9 months of uranium
contamination (Souidi et al. 2005), our results confirmed
the absence of disease in these animals. Measurements of
standard clinical biomarkers and biometric variables during
and after treatment were similar in both experimental
groups. We did not observe any problem such as anorexia,
substantial weight loss, or macroscopically observable
tissue damage (including in the kidneys, which are well
known as a biological target of uranium in acute high-dose
contamination) and were thus able to rule out any deteri-
oration in health status. Nor did we observe any imbalance
between the groups for CBC, in hepatic, heart, and kidney
enzyme activities, or in lipid, protein, and ion concentra-
tions in plasma. Markers of potential nephropathy, such as
urine volume, liver enzyme concentration, carbohydrates
and creatinine clearance were also measured and showed
no changes (the few statistically significant changes
observed nonetheless still remained within the range of
physiologically normal).
It is well recognized that uranium has a dual toxicity,
radiological (as an alpha emitter) and chemical (as a heavy
metal) (Craft et al. 2004). When it includes substantial
proportions of isotope 234 or 235, as enriched uranium
does, it may be more radiologically than chemically toxic.
For depleted or nat.U, however, chemical toxicity is more
important. Our data confirmed the absence of both types of
toxicity. In fact, the low renal burden of uranium (around
300 ng/g of tissue) in this study, compared to the 3 lg/g
value traditionally assumed as the threshold of renal tox-
icity (Leggett 1989), confirms the low-dose nature of the
contamination of the rats in this study, as does the very low
total absorbed dose calculated (150 lGy). In conclusion,
this level of contamination is consistent with the measured
renal effects, which did not demonstrate any associated
disease or deterioration in general health status after
9 months of contamination with nat.U.
Nonetheless, the absence of toxicity does not imply a
lack of biological effects that might be detected by more
sensitive techniques. This was clearly demonstrated when
we used metabolomics to identify chronic low-dose expo-
sure to cesium 137. As with 137Cs, the metabolomics
approach applied here was quite able to discriminate the
control animals from the uranium-contaminated rats. Ura-
nium, as a heavy metal, accumulates specifically in target
organs, especially the kidneys (Paquet et al. 2006). The
significant discrimination between nat.U non-exposed and
exposed rats that we found in urine thus appears consistent
with tubular accumulation of uranium and its consequent
nephrotoxicity on exposure to higher doses (Blantz 1975;
Haley et al. 1982). A similar metabolomics plasma inves-
tigation would be nevertheless worth to perform.
The most discriminatory metabolite was identified as N1-
methylnicotinamide, found at a concentration seven times
higher in the urine of control versus contaminated rats. A
decrease in this metabolite has previously been described as
an indicator of induced nephropathy, by administration of a
single high dose of uranium (Shim et al. 1984). Our results
might thus suggest early biological nephron response after
9 months of chronic low-dose ingestion of nat.U. They also
indicate that the nicotinamide pathway is a potential target
for uranium. For instance, the urine content of several
metabolites belonging to this pathway were changed by nat.U
contamination. Among them was N1-methyl-pyridone-
5carboxamide that increased by nat.U (Table 2), which is the
product of N1-methylnicotinamide oxydo-reduction by the
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aldehyde oxidase EC:1.2.3.1 (supplemental Fig. 5). Thus
suggesting that this converting enzyme can be a target for
nat.U biological effect. In addition, as pointed out above
uranium interferes with the cytochrome P450, Vitamin D,
cholesterol, and xenobiotic metabolisms: all these pathways
use the enzyme cofactor nicotinamide adenine dinucleotide
phosphate (NADP). Further targeted searches on this path-
way would probably be especially useful to decrypt the
underlying mechanisms by which uranium acts on these
metabolisms.
We also identified creatine, 4,6-dihydroxyquinoline, and
5-hydroxyindoleacetic acid as highly discriminatory fea-
tures (ranked 6th, 11th, and 32nd in the PLS-DA model,
respectively). Based on these identified metabolites and 10
tentatively annotated ones (based on database searching),
chronic low-dose nat.U contamination appears to affect
mainly the tryptophan and the nicotinamide metabolism
pathways. N1-methylnicotinamide alone allowed 100 %
discrimination with 100 % specificity and selectivity.
Nevertheless, the risk of inaccuracy in relying on only one
bioindicator could be high, since conditions other than
uranium contamination might affect the level of this
metabolite in urine. It would thus be wiser to use a com-
bination of bioindicators, so that the potential failure of one
would be offset by the others in the calculation of a global
score reflecting uranium contamination more specifically.
Such a strategy would be advantageous for designing a
diagnostic test. In that perspective, we used the top 40
discriminatory metabolites from the PLS-DA model to
build a composite score, and calculated its AUC under the
ROC curve; this reached 98 % (CI 92–100 %) (Fig. 3).
In conclusion, this study confirms that the application of
metabolomics is relevant to the field of chronic low-dose
radiotoxicology, more so than more traditional techniques
that lack sensitivity and seem unsuitable to exploring rel-
atively minor or uneventful biological effects. Further work
is needed to validate our findings. Such work should
include a replication study with validation cohorts, radio-
nuclide dose–response assessment, contamination kinetics,
and a comparison of response by sex to investigate the
physiological mechanisms responsible for the biological
changes highlighted by metabolomics. The intensity of the
biological effects measured and whether it exceeds the
threshold of disease must also be clarified.
The noninvasive use of urine as a reproducible biofluid
and validation of our other findings should make it possible
to design a diagnostic tool able to sort populations poten-
tially contaminated by environmental nat.U.
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